Nalaganje...

Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma

Neuroblastoma is a pediatric cancer of the developing sympathetic nervous system. High-risk neuroblastoma patients typically undergo an initial remission in response to treatment, followed by recurrence of aggressive tumors that have become refractory to further treatment. The need for biomarkers th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Inform
Main Authors: Utnes, Peter, Løkke, Cecilie, Flægstad, Trond, Einvik, Christer
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6413431/
https://ncbi.nlm.nih.gov/pubmed/30886518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1176935119832910
Oznake: Označite
Brez oznak, prvi označite!